X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (193) 193
Book Chapter (29) 29
Book Review (22) 22
Publication (16) 16
Government Document (4) 4
Book / eBook (2) 2
Conference Proceeding (2) 2
Reference (1) 1
Report (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (106) 106
humans (103) 103
female (86) 86
endocrinology & metabolism (81) 81
osteoporosis (72) 72
middle aged (56) 56
aged (55) 55
postmenopausal women (50) 50
osteoporosis, postmenopausal - drug therapy (35) 35
abridged index medicus (33) 33
alendronate (30) 30
bone density (30) 30
bone density - drug effects (28) 28
bone-mineral density (27) 27
osteoporosis - drug therapy (27) 27
women (27) 27
fractures (26) 26
teriparatide (26) 26
bone density conservation agents - therapeutic use (24) 24
male (24) 24
density (19) 19
aged, 80 and over (18) 18
fracture (17) 17
postmenopausal osteoporosis (17) 17
risk (17) 17
therapy (17) 17
bisphosphonates (16) 16
hip fracture (16) 16
mineral density (16) 16
parathyroid-hormone 1-34 (16) 16
zoledronic acid (16) 16
adult (15) 15
bone density conservation agents - administration & dosage (15) 15
bone mineral density (15) 15
diphosphonates - therapeutic use (15) 15
drug administration schedule (15) 15
parathyroid hormone (15) 15
parathyroid-hormone (15) 15
treatment outcome (15) 15
medicine, general & internal (14) 14
risk factors (14) 14
health aspects (13) 13
vertebral fracture (13) 13
bone density conservation agents - adverse effects (12) 12
bones (12) 12
drug therapy (12) 12
estrogen (12) 12
orthopedics (12) 12
prevention (12) 12
teriparatide - therapeutic use (12) 12
alendronate - therapeutic use (11) 11
mass (11) 11
analysis (10) 10
double-blind method (10) 10
drug therapy, combination (10) 10
raloxifene (10) 10
randomized-trial (10) 10
teriparatide - administration & dosage (10) 10
teriparatide - pharmacology (10) 10
vertebral fractures (10) 10
absorptiometry, photon (9) 9
denosumab (9) 9
epidemiology (9) 9
fracture risk (9) 9
fractures, bone - prevention & control (9) 9
hip (9) 9
medicine & public health (9) 9
osteoporosis, postmenopausal - physiopathology (9) 9
postmenopause (9) 9
randomized controlled-trial (9) 9
risedronate (9) 9
alendronate - administration & dosage (8) 8
animals (8) 8
biochemical markers (8) 8
calcium - blood (8) 8
cancellous bone (8) 8
diphosphonates - administration & dosage (8) 8
diphosphonates - adverse effects (8) 8
imidazoles - therapeutic use (8) 8
nonvertebral fractures (8) 8
obstetrics & gynecology (8) 8
original (8) 8
osteoporosis - complications (8) 8
osteoporosis - physiopathology (8) 8
post-menopause (8) 8
risk assessment (8) 8
trial (8) 8
adolescent (7) 7
anabolic (7) 7
biomarkers - blood (7) 7
bone remodeling - drug effects (7) 7
bone turnover (7) 7
calcium (7) 7
care and treatment (7) 7
estrogen replacement therapy (7) 7
hormone replacement therapy (7) 7
injections, subcutaneous (7) 7
menopause (7) 7
parathyroid hormone - administration & dosage (7) 7
radiography (7) 7
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
OISE - Stacks (1) 1
Online Resources - Online (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Opinion in Rheumatology, ISSN 1040-8711, 07/2019, Volume 31, Issue 4, pp. 376 - 380
PURPOSE OF REVIEWMany physicians have long considered anabolic osteoporosis medication to be the last resort for patients after multiple fractures have already... 
romosozumab | bone building | DENOSUMAB | PREVENTION | EXTENSION | teriparatide | RHEUMATOLOGY | FRACTURE RISK | ALENDRONATE | ZOLEDRONIC ACID | abaloparatide | anabolic | POSTMENOPAUSAL WOMEN | Drug therapy | Osteoporosis
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2007, Volume 356, Issue 18, pp. 1809 - 1822
Journal Article
BoneKEy reports, ISSN 2047-6396, 2015, Volume 4, pp. 661 - 661
Journal Article
JAMA, ISSN 0098-7484, 08/2016, Volume 316, Issue 7, pp. 722 - 733
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 16, pp. 1532 - 1543
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 02/2012, Volume 27, Issue 2, pp. 243 - 254
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 11/2010, Volume 25, Issue 11, pp. 2267 - 2294
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 4, pp. 396 - 397
Journal Article
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 03/2011, Volume 26, Issue 3, pp. 503 - 511
Clinical data suggest concomitant therapy with bisphosphonates and parathyroid hormone (PTH) may blunt the anabolic effect of PTH; rodent models suggest that... 
ZOLEDRONIC ACID | INFUSION | TERIPARATIDE | BISPHOSPHONATE | OSTEOPOROSIS | Bisphosphonate | teriparatide | infusion | osteoporosis | zoledronic acid | BONE-MINERAL DENSITY | PARATHYROID-HORMONE 1-34 | ALENDRONATE | WOMEN | FRACTURE | BISPHOSPHONATES | THERAPY | CANCELLOUS BONE | MASS | ENDOCRINOLOGY & METABOLISM | PROXIMAL FEMUR | Collagen Type I - blood | Peptides - blood | Injections, Intravenous | Teriparatide - therapeutic use | Bone Density - physiology | Follow-Up Studies | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Imidazoles - administration & dosage | Osteoporotic Fractures - drug therapy | Bone Remodeling - physiology | Injections, Subcutaneous | Peptide Fragments - blood | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteoporotic Fractures - physiopathology | Diphosphonates - adverse effects | Biomarkers - metabolism | Bone Density Conservation Agents - adverse effects | Teriparatide - administration & dosage | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Diphosphonates - administration & dosage | Procollagen - blood | Bone Density Conservation Agents - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Osteoporosis, Postmenopausal - blood | Osteoporotic Fractures - complications | Least-Squares Analysis | Osteoporosis, Postmenopausal - physiopathology | Teriparatide - adverse effects | Aged | Osteoporotic Fractures - blood | Index Medicus
Journal Article